PRESS RELEASE published on 05/11/2023 at 22:25, 3 years 5 months ago Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity
PRESS RELEASE published on 05/08/2023 at 12:30, 3 years 5 months ago Zomedica Exercises Option to Acquire Structured Monitoring Products
PRESS RELEASE published on 05/02/2023 at 12:30, 3 years 6 months ago Zomedica to Host First Quarter Financial Results Call on May 11
PRESS RELEASE published on 04/18/2023 at 12:30, 3 years 6 months ago Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
PRESS RELEASE published on 03/17/2023 at 11:30, 3 years 7 months ago Zomedica Appoints New Chief Financial Officer
PRESS RELEASE published on 03/15/2023 at 21:45, 3 years 7 months ago Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth
PRESS RELEASE published on 03/08/2023 at 12:30, 3 years 7 months ago Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15
PRESS RELEASE published on 02/09/2023 at 12:30, 3 years 8 months ago Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022
PRESS RELEASE published on 01/24/2023 at 12:00, 3 years 9 months ago Zomedica to Participate in the Lytham Partners Investor Select Conference
PRESS RELEASE published on 01/18/2023 at 12:00, 3 years 9 months ago Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
Published on 11/04/2026 at 23:10, 1 hour 55 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 2 hours 5 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 2 hours 50 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 3 hours ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 00:02, 1 hour 2 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 5 hours 24 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 5 hours 40 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 6 hours 22 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 7 hours ago Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 18:00, 7 hours 5 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 7 hours 5 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 7 hours 21 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
